Bo Ahrén

researcher

Born 1952-04-19

Bo Ahrén is …
instance of (P31):
humanQ5

External links are
P213ISNI0000000387807351
P496ORCID iD0000-0002-9804-5340
P7293PLWABN ID9810607130005606
P2038ResearchGate profile IDBo_Ahren
P214VIAF ID315221734

P27country of citizenshipSwedenQ34
P108employerLund UniversityQ218506
P22fatherPer-Olov AhrénQ5544511
P735given nameBoQ1234223
BoQ1234223
P106occupationphysicianQ39631
P39position heldboard memberQ2824523
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q584487911,5-Anhydro-d-fructose increases glucose tolerance by increasing glucagon-like peptide-1 and insulin in mice
Q5792021935th Annual Meeting of the European Association for the Study of Diabetes
Q5688384435th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999
Q5683608440 EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004
Q30997105A 90-day toxicological evaluation of 1,5-anhydro-d-fructose in Sprague-Dawley rats
Q28307231A Palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet in individuals with ischaemic heart disease
Q21245074A Paleolithic diet confers higher insulin sensitivity, lower C-reactive protein and lower blood pressure than a cereal-based diet in domestic pigs
Q67534322A new dextran 40-based solution for liver preservation
Q46937429A novel approach to assess insulin sensitivity reveals no increased insulin sensitivity in mice with a dominant-negative mutant hepatocyte nuclear factor-1alpha
Q24621806A paleolithic diet is more satiating per calorie than a mediterranean-like diet in individuals with ischemic heart disease
Q71518718A role for islet peptide YY in the regulation of insulin secretion
Q58329818A strong association between biologically active testosterone and leptin in non-obese men and women is lost with increasing (central) adiposity
Q74352496Abnormal cytokine and adrenocortical hormone regulation in myotonic dystrophy
Q43913459Abnormal release of incretins and cortisol after oral glucose in subjects with insulin-resistant myotonic dystrophy
Q68019052Acetic acid-induced colitis in the rat: a reproducible experimental model for acute ulcerative colitis
Q73303080Activation of autonomic nerves and the adrenal medulla contributes to increased glucagon secretion during moderate insulin-induced hypoglycemia in women
Q73807086Acylation stimulating protein stimulates insulin secretion
Q53550245Adrenal incidentaloma - follow-up results from a Swedish prospective study.
Q42446036Adrenergic innervation of pancreatic islets and modulation of insulin secretion by the sympatho-adrenal system
Q71507388Adrenomedullin: localization in the gastrointestinal tract and effects on insulin secretion
Q51321430Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro.
Q44746434Aged transgenic mice with increased glucocorticoid sensitivity in pancreatic beta-cells develop diabetes
Q21256397Agrarian diet and diseases of affluence--do evolutionary novel dietary lectins cause leptin resistance?
Q50207588Alain Ktorza, PhD.
Q40296997Albiglutide for the treatment of type 2 diabetes mellitus: An integrated safety analysis of the HARMONY phase 3 trials
Q34559941Alpha 1- and alpha 2-adrenoceptor activation increases plasma glucagon levels in the mouse
Q34560507Alpha cell function in health and disease: influence of glucagon-like peptide-1.
Q69914209Alpha-adrenoceptor blockade by phentolamine inhibits beta-adrenergically and cholinergically induced glucagon secretion in the mouse
Q44517923Alteration of the counterregulatory responses to insulin-induced hypoglycemia and of cognitive function after massive weight reduction in severely obese subjects
Q42516520Altered beta-cell distribution of pdx-1 and GLUT-2 after a short-term challenge with a high-fat diet in C57BL/6J mice
Q46136142Altered glucose tolerance in women with deliberate self-harm
Q50988559Androgen activity as a risk factor for impaired glucose tolerance in postmenopausal women
Q44122845Anti-diabetogenic effect of the human amylin analogue, pramlintide, in Type 1 diabetes is not mediated by GLP-1.
Q73555568Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes
Q43674711Antidiabetogenic action of glucagon-like peptide-1 related to administration relative to meal intake in subjects with type 2 diabetes
Q45306841Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus
Q83226453Are sulfonylureas less desirable than DPP-4 inhibitors as add-on to metformin in the treatment of type 2 diabetes?
Q82286447Arterial gastroduodenal infusion of cholecystokinin-33 stimulates the exocrine pancreatic enzyme release via an enteropancreatic reflex, without affecting the endocrine insulin secretion in pigs
Q36218117Assessment of insulin secretion in relation to insulin resistance
Q46815300Autonomic control of pancreatic polypeptide and glucagon secretion during neuroglucopenia and hypoglycemia in mice
Q35080966Autonomic mechanism and defects in the glucagon response to insulin-induced hypoglycaemia
Q53762233Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired alpha-cell responses in type 1 diabetes.
Q51706573Autonomic neuropathy is associated with impaired pancreatic polypeptide and neuropeptide Y responses to insulin-induced hypoglycaemia in Type I diabetic patients.
Q26827955Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes
Q40518029Basic toxicology and metabolism studies of 1,5-anhydro-D-fructose using bacteria, cultured mammalian cells, and rodents
Q24654138Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study
Q43542656Beta cell adaptation to dexamethasone-induced insulin resistance in rats involves increased glucose responsiveness but not glucose effectiveness
Q33223590Beta-cell expression of a dominant-negative HNF-1alpha compromises the ability of inhibition of dipeptidyl peptidase-4 to elicit a long-term augmentation of insulin secretion in mice
Q31131767Beta-cell-targeted expression of a dominant-negative mutant of hepatocyte nuclear factor-1alpha in mice: diabetes model with beta-cell dysfunction partially rescued by nonglucose secretagogues
Q28594896Beta-cell-targeted overexpression of phosphodiesterase 3B in mice causes impaired insulin secretion, glucose intolerance, and deranged islet morphology
Q46915411Binding and the effect of the red kidney bean lectin, phytohaemagglutinin, in the gastrointestinal tract of suckling rats
Q43533303Biochemical determination of islet lysosomal enzyme activities following crinophagy-stimulating treatment with diazoxide in mice.
Q72074590Blockade of galanin-induced inhibition of insulin secretion from isolated mouse islets by the non-methionine containing antagonist M35
Q71458211Blockade of muscarinic transmission increases the frequency of diabetes after low-dose alloxan challenge in the mouse
Q39681233Body adiposity, insulin, and leptin in subgroups of Peruvian Amerindians
Q80449927Body fat related to daily physical activity and insulin concentrations in non-diabetic children
Q38336901Both leptin and leptin-receptor are essential for apolipoprotein M expression in vivo
Q45147939Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet.
Q38354850Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genes
Q51685119CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
Q33216230CART knock out mice have impaired insulin secretion and glucose intolerance, altered beta cell morphology and increased body weight
Q40983021CCK receptor subtype in insulin-producing cells: a combined functional and in situ hybridization study in rat islets and a rat insulinoma cell line
Q68011395CCK-8-stimulated insulin secretion in vivo is mediated by CCKA receptors
Q45060384CCKA receptor antagonism inhibits mechanisms underlying CCK-8-stimulated insulin release in isolated rat islets
Q37602697Calcitonin gene-related peptide (CGRP) and amylin and the endocrine pancreas.
Q43531338Calcitonin gene-related peptide inhibits insulin secretion studies on ion fluxes and cyclic AMP in isolated rat islets
Q42521611Calcitonin gene-related peptide: occurrence in pancreatic islets in the mouse and the rat and inhibition of insulin secretion in the mouse
Q57226862Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma
Q69738590Calcium stimulates the release of calcitonin gene-related peptide from the canine thyroid
Q51601381Capacity to secrete islet hormones after subtotal pancreatectomy for pancreatic cancer.
Q74578914Capsaicin-induced sensory denervation increases glucose elimination in rodents
Q51480280Capsaicin-sensitive sensory fibers in the islets of Langerhans contribute to defective insulin secretion in Zucker diabetic rat, an animal model for some aspects of human type 2 diabetes.
Q43542662Carbachol restores insulin release in diabetic GK rat islets by mechanisms largely involving hydrolysis of diacylglycerol and direct interaction with the exocytotic machinery
Q48094566Cerebrospinal fluid insulin during non-neurological surgery
Q33751433Changes in prandial glucagon levels after a 2-year treatment with vildagliptin or glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapy
Q44599743Characterization of GLP-1 effects on beta-cell function after meal ingestion in humans
Q70193660Cholecystokinin (CCK)-33 stimulates insulin secretion from the perfused rat pancreas: studies on the structure-activity relationship
Q69920267Cholecystokinin (CCK)-4 and CCK-8 stimulate islet hormone secretion in vivo in the pig
Q35692812Cholecystokinin and the regulation of insulin secretion
Q68147839Cholecystokinin-33 potentiates and vasoactive intestinal polypeptide inhibits gastric inhibitory polypeptide--induced insulin secretion in the perfused rat pancreas
Q44531334Cholecystokinin-stimulated insulin secretion and protein kinase C in rat pancreatic islets
Q36616404Cholinergic regulation of the endocrine pancreas
Q42488484Chronic glucokinase activation reduces glycaemia and improves glucose tolerance in high-fat diet fed mice
Q43542496Circulating IGF binding protein-1 is inversely associated with leptin in non-obese men and obese postmenopausal women
Q45387158Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes
Q37825941Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin
Q38083641Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin
Q37160675Clinical measures of islet function: usefulness to characterize defects in diabetes
Q37595942Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin--diabetes control and potential adverse events
Q45296755Comparative evaluation of simple insulin sensitivity methods based on the oral glucose tolerance test
Q54294726Comparison of effects of neuropeptide Y and norepinephrine on insulin secretion and vascular resistance in perfused rat pancreas.
Q51314476Conditional glucagon receptor overexpression has multi-faceted consequences for beta-cell function.
Q97682155Consequences on islet and incretin hormone responses to dinner by omission of lunch in healthy men
Q67850206Contribution of adrenergic nerves and the adrenals to 2-Deoxy-D-glucose-induced insulin and glucagon secretion in the mouse
Q67705277Contribution of galanin to stress-induced impairment of insulin secretion in swimming mice
Q72681724Contribution of liver nerves, glucagon, and adrenaline to the glycaemic response to exercise in rats
Q43733884Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice
Q82790982Contributions from the first SICOD (Swedish-Italian Cooperation on Diabetes Research) meeting, Stockholm, Sweden, October 2004
Q28293086Correlation of apolipoprotein M with leptin and cholesterol in normal and obese subjects
Q61774897Cortisol axis abnormalities early after stroke - relationships to cytokines and leptin
Q39027188Creative use of novel glucose-lowering drugs for type 2 diabetes: where will we head in the next 50 years?
Q69499448Cysteamine and the endocrine pancreas: immunocytochemical, immunochemical, and functional aspects
Q52536208Cytosolic Ca2+ oscillations by gastrin releasing peptide in single HIT-T15 cells.
Q91638366DPP-4 Inhibition and the Path to Clinical Proof
Q27028127DPP-4 inhibition and islet function
Q86689215DPP-4 inhibition contributes to the prevention of hypoglycaemia through a GIP-glucagon counterregulatory axis in mice
Q51754123DPP-4 inhibition improves glucose tolerance and increases insulin and GLP-1 responses to gastric glucose in association with normalized islet topography in mice with beta-cell-specific overexpression of human islet amyloid polypeptide.
Q33308406DPP-4 inhibitors
Q50152436DPP-4 is expressed in human pancreatic beta cells and its direct inhibition improves beta cell function and survival in type 2 diabetes
Q50889725Deciphering the Hypoglycemic Glucagon Response: Development of a Graded Hyperinsulinemic Hypoglycemic Clamp Technique in Female Mice
Q51292778Decreased insulin secretion and glucose clearance in exocrine pancreas-insufficient pigs.
Q86963296Defective insulin secretion by chronic glucagon receptor activation in glucose intolerant mice
Q42135711Dependence on extracellular Ca2+ for the effects of cholecystokinin-8 in rat pancreatic islets
Q44485081Determinants of serum triglycerides and high-density lipoprotein cholesterol in traditional Trobriand Islanders: the Kitava Study
Q43593468Determination of thyroxine release in vivo: a simple, specific and sensitive method in mice
Q41115408Dexamethasone induces neuropeptide Y (NPY) expression and impairs insulin release in the insulin-producing cell line RINm5F. Release of NPY and insulin through different pathways
Q71580039Dexamethasone-induced neuropeptide Y expression in rat islet endocrine cells. Rapid reversibility and partial prevention by insulin
Q44381337Diabetes and impaired fasting glycemia in a rural population of Bangladesh
Q36930635Diazepam binding inhibitor and the endocrine pancreas
Q38583953Dietary Fibre in Type II Diabetes
Q51246154Different glucagon effects during DPP-4 inhibition versus SGLT-2 inhibition in metformin-treated type 2 diabetes patients.
Q72223899Different mechanisms are involved in neuropeptide Y-induced pancreatic vasoconstriction and inhibition of insulin secretion
Q54024294Differential changes in islet amyloid polypeptide (amylin) and insulin mRNA expression after high-fat diet-induced insulin resistance in C57BL/6J mice.
Q36395742Differential development of glucose intolerance and pancreatic islet adaptation in multiple diet induced obesity models
Q73158791Differential effect of insulin treatment on islet amyloid polypeptide (amylin) and insulin gene expression in streptozotocin-induced diabetes in rats
Q43515497Differential effects of glucagon-like peptide-1 (7-36)amide versus cholecystokinin on arginine-induced islet hormone release in vivo and in vitro
Q71172536Differential expression of islet amyloid polypeptide (amylin) and insulin in experimental diabetes in rodents
Q43848935Differential impairment of glucagon responses to hypoglycemia, neuroglycopenia, arginine, and carbachol in alloxan-diabetic mice
Q42164402Differential islet and incretin hormone responses in morning versus afternoon after standardized meal in healthy men.
Q46878138Dipeptidyl peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from individuals with type 2 diabetes
Q46832007Dipeptidyl peptidase-4 (DPP-4): Localization and activity in human and rodent islets
Q44143356Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials
Q31104386Dipeptidyl peptidase-4 inhibitors: clinical data and clinical implications
Q31855529Direct cytoplasmic CA(2+) responses to gastrin-releasing peptide in single beta cells
Q33968320Disassociated relation between plasma tumor necrosis factor-alpha, interleukin-6 and increased body weight in Amerindian women: A long-term prospective study of natural body weight variation and impaired glucose tolerance
Q43163423Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice
Q45926538Dissociated incretin response to oral glucose at 1 year after restrictive vs. malabsorptive bariatric surgery.
Q73006830Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice
Q36744260Disturbed alpha-cell function in mice with beta-cell specific overexpression of human islet amyloid polypeptide
Q39054666Diurnal glucose exposure profiles of patients treated with lixisenatide before breakfast or the main meal of the day: An analysis using continuous glucose monitoring
Q54113450Does galanin inhibit insulin secretion by opening of the ATP-regulated K+ channel in the beta-cell?
Q44315351Dose-dependent inhibition by ghrelin of insulin secretion in the mouse
Q54068522Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice.
Q40303682Down-regulation of apolipoprotein M expression is mediated by phosphatidylinositol 3-kinase in HepG2 cells
Q44414146Downregulation of islet hormone-sensitive lipase during long-term high-fat feeding
Q45052330Dual action of adiponectin on insulin secretion in insulin-resistant mice
Q68084167Dual effects of calcitonin gene-related peptide on insulin secretion in the perfused dog pancreas
Q44576271Dual effects of pituitary adenylate cyclase-activating polypeptide and isoproterenol on lipid metabolism and signaling in primary rat adipocytes
Q53331571Dual relation between leptin and cortisol in humans is disturbed in Alzheimer's disease.
Q33317451Durable islet effects on insulin secretion and protein kinase A expression following exendin-4 treatment of high-fat diet-fed mice
Q51497454Early and rapid development of insulin resistance, islet dysfunction and glucose intolerance after high-fat feeding in mice overexpressing phosphodiesterase 3B.
Q69878472Effect and mechanism of vagal nerve stimulation on somatostatin secretion in dogs
Q74582543Effect of 3-O-methylglucose on insulin secretion in the perfused dog and rat pancreas
Q70216266Effect of Dietary Fibre on Blood Glucose, Plasma Immunoreactive Insulin, C-peptide and GIP Responses in non Insulin Dependent (Type 2) Diabetics and Controls
Q90348841Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections
Q46689843Effect of a conjugated linoleic acid and omega-3 fatty acid mixture on body composition and adiponectin
Q72314127Effect of bile obstruction on liver regeneration following major hepatectomy: an experimental study in the rat
Q72892797Effect of inhibition of protein synthesis on thyroid cyclic AMP accumulation in vitro
Q64081823Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI-liraglutide study 5)
Q57222866Effect of phosphatidylcholine on postoperative adhesions after small bowel anastomosis in the rat
Q48142030Effect of single-dose DPP-4 inhibitor sitagliptin on β-cell function and incretin hormone secretion after meal ingestion in healthy volunteers and drug-naïve, well-controlled type 2 diabetes subjects
Q51294562Effect of the GLP-1 Receptor Agonist Lixisenatide on Counterregulatory Responses to Hypoglycemia in Subjects With Insulin-Treated Type 2 Diabetes.
Q42467449Effects of 4-aminopyridine on insulin secretion and plasma glucose levels in intact and adrenalectomized-chemically sympathectomized mice
Q68109833Effects of CCK-8 on the cytoplasmic free calcium concentration in isolated rat islet cells
Q37696575Effects of DPP-4 inhibitor linagliptin and GLP-1 receptor agonist liraglutide on physiological response to hypoglycaemia in Japanese subjects with type 2 diabetes: A randomized, open-label, 2-arm parallel comparative, exploratory trial
Q40095941Effects of Dexamethasone, Desoxycorticosterone, and ACTH on Serum Concentrations of Thyroxine, 3, 5, 3′-Triiodothyronine and 3, 3‘, 5’-Triiodothyronine
Q71813539Effects of GLP-1 and 2,5-anhydro-D-mannitol on insulin secretion and plasma glucose in mice
Q67464635Effects of Galanin and Norepinephrine on Insulin Secretion in the Mouse
Q69897096Effects of alpha 1- and alpha 2-adrenoceptor stimulation and blockade on plasma insulin levels in the mouse
Q72572298Effects of alpha 1-, alpha 2- and beta-adrenoceptor blockers on insulin secretion in the rat
Q69870874Effects of alpha- and beta-adrenoceptor stimulation on 45Ca2+ efflux and insulin secretion from perfused rat islets
Q69873953Effects of alpha-adrenoceptor blockade by phentolamine on basal and stimulated insulin secretion in the mouse
Q51587077Effects of arginine on the secretion of insulin and islet amyloid polypeptide in humans.
Q51867889Effects of autonomic blockade by methylatropine and optical isomers and propranolol on plasma insulin levels in the basal state and after stimulation.
Q43521338Effects of calcitonin gene-related peptide (CGRP) on islet hormone secretion in the pig.
Q32062812Effects of chemical sympathectomy by means of 6-hydroxydopamine on insulin secretion and islet morphology in alloxan-diabetic mice
Q43947295Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man
Q70942088Effects of cholecystokinin and glucagon-like peptide 1 on the secretion of pancreatic polypeptide in mice
Q44985760Effects of conjugated linoleic acid plus n-3 polyunsaturated fatty acids on insulin secretion and estimated insulin sensitivity in men.
Q48136280Effects of corticotropin-releasing hormone on insulin and glucagon secretion in mice.
Q69090891Effects of galanin on insulin and glucagon secretion in the rat
Q70942060Effects of galanin on proinsulin mRNA and insulin biosynthesis in normal islets
Q42467000Effects of glicentine on insulin secretion
Q68900574Effects of glipizide on various consecutive insulin secretory stimulations in patients with type 2 diabetes
Q71526624Effects of glucagon and pentagastrin on glibenclamide-induced insulin release
Q72693519Effects of glucagon like peptide-1(7-36) amide on the cytoplasmic Ca(2+)-concentration in rat islet cells
Q53886146Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.
Q51577056Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus.
Q51581175Effects of glucagon-like peptide-I on glucose turnover in rats.
Q44921536Effects of high-fat feeding and fasting on ghrelin expression in the mouse stomach
Q35801801Effects of increasing doses of glucagon-like peptide-1 on insulin-releasing phases during intravenous glucose administration in mice
Q72393119Effects of naloxone on basal and stimulated insulin secretion in the mouse
Q70143998Effects of norepinephrine on basal and thyrotropin-stimulated thyroid hormone secretion in the mouse
Q69930371Effects of pancreatic noradrenaline infusion on basal and stimulated islet hormone secretion in the dog
Q72707636Effects of pectin on glycaemia and insulinaemia after starch loading in normal, alloxan diabetic, and pancreatic duct-occluded rats
Q42465957Effects of porcine diazepam-binding inhibitor on insulin and glucagon secretion in vitro from the rat endocrine pancreas
Q72475533Effects of selective and non-selective β-adrenergic agents on insulin secretion in vivo
Q44212936Effects of six cholecystokinin (CCK) fragments on insulin secretion in the mouse.
Q42488166Effects of the three neuropeptides, vasoactive intestinal peptide, substance P, and calcitonin gene related peptide on basal and stimulated calcitonin release in the rat.
Q69491589Effects of three different cholecystokinin receptor antagonists on basal and stimulated insulin and glucagon secretion in mice
Q67259585Effects of thyrotrophin stimulation for two hours on mouse thyroid cyclic AMP levels in vivo and in vitro
Q67276620Effects of vasoactive intestinal polypeptide (VIP), secretin and gastrin on insulin secretion in the mouse
Q72555240Effects of β-adrenoceptor agonists and antagonists on thyroid hormone secretion
Q88338508Effects on the glucagon response to hypoglycaemia during DPP-4 inhibition in elderly subjects with type 2 diabetes: A randomized, placebo-controlled study
Q40422929Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc Analysis
Q51593492Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial.
Q37106572Efficacy and safety of lixisenatide once-daily morning or evening injections in type 2 diabetes inadequately controlled on metformin (GetGoal-M).
Q53372791Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial.
Q87595911Efficacy of lixisenatide in patients with type 2 diabetes: A post hoc analysis of patients with diverse β-cell function in the GetGoal-M and GetGoal-S trials
Q87558803Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies
Q82787527Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes
Q40360642Enhanced insulin sensitivity mediated by adipose tissue browning perturbs islet morphology and hormone secretion in response to autonomic nervous activation in female mice
Q72538452Enhancement of insulin secretion during selective blockade of alpha 1- and alpha 2-adrenoceptors in the rat: effects of somatostatin
Q51319202Equal improvement in glycaemia with lixisenatide given before breakfast or the main meal of the day.
Q44808610Estimated intake of milk fat is negatively associated with cardiovascular risk factors and does not increase the risk of a first acute myocardial infarction. A prospective case-control study
Q37222837Estimation of the Relative Contribution of Postprandial Glucose Exposure to Average Total Glucose Exposure in Subjects with Type 2 Diabetes.
Q72789853Evidence for an influence of the peri-arterial hepatic nerves on basal insulin-secretion in the rat
Q40992469Evidence for contribution by increased cytoplasmic Na+ to the insulinotropic action of PACAP38 in HIT-T15 cells
Q51566222Evidence for leptin regulation of food intake in humans.
Q87502480Evidence for neural contribution to islet effects of DPP-4 inhibition in mice
Q54641355Evidence for the presence of glucose cycling in pancreatic islets of the ob/ob mouse.
Q87094005Evidence for time dependent variation of glucagon secretion in mice
Q46931625Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver
Q38325069Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model
Q68251444Extraction of epinephrine and norepinephrine by the dog pancreas in vivo
Q72928143Factors influencing the release of cyclic AMP from mouse thyroid tissue stimulated by TSH in vitro
Q68504056Failure of islet amyloid polypeptide to inhibit basal and glucose-stimulated insulin secretion in model experiments in mice and rats
Q44303373Failure of somatostatin to eliminate the glucagon release induced by baroreceptor unloading in the cat
Q51579831Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance.
Q51587936Fasting blood glucose in determining the prevalence of diabetes in a large, homogeneous population of Caucasian middle-aged women.
Q35721830Fasting until noon triggers increased postprandial hyperglycemia and impaired insulin response after lunch and dinner in individuals with type 2 diabetes: a randomized clinical trial
Q44449211Fat feeding impairs glycogen synthase activity in mice without effects on its gene expression
Q86026330Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice
Q51300354Fibroblast growth factor 21 prevents glycemic deterioration in insulin deficient mouse models of diabetes.
Q46173840Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy
Q35846876Four-Point Preprandial Self-Monitoring of Blood Glucose for the Assessment of Glycemic Control and Variability in Patients with Type 2 Diabetes Treated with Insulin and Vildagliptin
Q35661969Four-Year Durability of Initial Combination Therapy with Sitagliptin and Metformin in Patients with Type 2 Diabetes in Clinical Practice; COSMIC Study
Q36892888Function of reduced-size liver transplant in the rat.
Q27865197G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes.
Q42472192GLP-1 and GLP-1(7-36) amide: influences on basal and stimulated insulin and glucagon secretion in the mouse
Q33794098GLP-1 for type 2 diabetes
Q36012529GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes
Q33745485GLP-1 released to the mesenteric lymph duct in mice: effects of glucose and fat.
Q38554472GLP-1 tablet in type 2 diabetes in fasting and postprandial conditions
Q67961395GLP-1(7-36)amide-stimulated insulin secretion in rat islets is sodium-dependent
Q37049674GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors
Q51800702GPR40 is expressed in glucagon producing cells and affects glucagon secretion.
Q38185571Galanin and the endocrine pancreas
Q35335134Galanin and the regulation of islet hormone secretion.
Q73521763Galanin exerts dual action on inositol-specific phospholipase C activity in isolated pancreatic islets
Q67699395Galanin fragments and analogues: effects on glucose-stimulated insulin secretion from isolated rat islets
Q69045811Galanin inhibits amylase secretion from isolated rat pancreatic acini
Q68977942Galanin inhibits glucose-stimulated insulin release by a mechanism involving hyperpolarization and lowering of cytoplasmic free Ca2+ concentration
Q67666998Galanin is co-localized with noradrenaline and neuropeptide Y in dog pancreas and celiac ganglion
Q71655908Galanin message-associated polypeptide (GMAP) does not affect insulin secretion from isolated islets
Q67676195Galanin of the homologous species inhibits insulin secretion in the rat and in the pig
Q28324014Galanin-immunoreactive nerves in the mouse and rat pancreas
Q67711020Galanin-induced inhibition of insulin secretion from rat islets: effects of rat and pig galanin and galanin fragments and analogues
Q36699745Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes
Q68967530Galanin: a novel pancreatic neuropeptide
Q68993054Galanin: effects on basal and stimulated insulin and glucagon secretion in the mouse
Q81880884Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type
Q68084952Gastrin releasing peptide stimulates the secretion of insulin, but not that of glucagon or somatostatin, from the isolated perfused dog pancreas
Q41245760Gastrin-releasing peptide mobilizes calcium from intracellular stores in HIT-T15 cells
Q43822360Gender difference in the glucagon response to glucopenic stress in mice
Q51473372Gender-specific links between hepatic 11beta reduction of cortisone and adipokines.
Q50891529Glucagon and GLP-1 exhibit no synergistic enhancement of glucose-stimulated insulin secretion in mice
Q93271430Glucagon and insulin secretion, insulin clearance, and fasting glucose in GIP receptor and GLP-1 receptor knockout mice
Q37626422Glucagon clearance is regulated by nutritional state: evidence from experimental studies in mice
Q57563922Glucagon dynamics during hypoglycaemia and food-re-challenge following treatment with vildagliptin in insulin-treated patients with type 2 diabetes
Q72670214Glucagon immunoreactivity in plasma from normal and dystrophic mice
Q46212121Glucagon increases insulin levels by stimulating insulin secretion without effect on insulin clearance in mice
Q33283676Glucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet
Q79386784Glucagon receptor knockout mice display increased insulin sensitivity and impaired beta-cell function
Q38392884Glucagon--Early breakthroughs and recent discoveries
Q51063362Glucagon-like peptide-1 accelerates the onset of insulin action on glucose disappearance in mice
Q33800196Glucagon-like peptide-1 and glucose-dependent insulinotropic peptide: effects alone and in combination on insulin secretion and glucose disappearance in mice
Q90901449Glucagon-like peptide-1 receptor agonists for type 2 diabetes: A rational drug development
Q58449011Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humans
Q71589117Glucagon-like peptide-1(7-36)amide and cytoplasmic calcium in insulin producing cells
Q100959656Glucose Effectiveness Lessons from Studies on Insulin-Independent Glucose Clearance in Mice
Q72278232Glucose homeostasis after peri-arterial hepatic denervation in partially hepatectomized rats
Q44717417Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: outcome of a prospective study in postmenopausal Caucasian women
Q51587985Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance.
Q68942609Glucose tolerance and insulin and C-peptide responses after various insulin secretory stimuli in hyper- and hypothyroid subjects before and after treatment
Q70593888Glucose tolerance and insulin secretion in experimental pancreatic cancer in the Syrian hamster
Q68533404Glucose tolerance and insulin secretion in experimental peritonitis in the rat
Q51618486Glucose turnover in rats undergoing transient dearterialization for liver malignancy.
Q47755819Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine
Q83181276Glucose-induced incretin hormone release and inactivation are differently modulated by oral fat and protein in mice
Q46985413Glucose-stimulated insulin secretion correlates with beta-cell lipolysis
Q34265490Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis
Q46808831Glycogen and glycogen-hydrolysing lysosomal enzyme activity in mouse liver: effects of fasting, adrenoceptor antagonism and insulin-induced hypoglycaemia
Q45096607Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood
Q45199123Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia
Q31157033Gut peptides and type 2 diabetes mellitus treatment
Q51321425HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin.
Q51562487Habitual dietary intake versus glucose tolerance, insulin sensitivity and insulin secretion in postmenopausal women.
Q68182434Hepatic sympathetic denervation potentiates glucagon-stimulated glycogenolysis and hyperinsulinaemia in the rat
Q86826081Hepato-incretin function of GLP-1: novel concept and target in type 1 diabetes
Q60639601High CSF-insulin in violent suicide attempters
Q48420056High leptin levels are associated with stroke
Q47190755High-energy breakfast based on whey protein reduces body weight, postprandial glycemia and HbA1C in Type 2 diabetes
Q86842730High-energy breakfast with low-energy dinner decreases overall daily hyperglycaemia in type 2 diabetic patients: a randomised clinical trial
Q34726350Higher Risk of Hypoglycemia with Glimepiride Versus Vildagliptin in Patients with Type 2 Diabetes is not Driven by High Doses of Glimepiride: Divergent Patient Susceptibilities?
Q44497632Hormone-sensitive lipase null mice exhibit signs of impaired insulin sensitivity whereas insulin secretion is intact
Q36662603Human islet amyloid polypeptide transgenic mice: in vivo and ex vivo models for the role of hIAPP in type 2 diabetes mellitus
Q24625957Identification, isolation, and characterization of daintain (allograft inflammatory factor 1), a macrophage polypeptide with effects on insulin secretion and abundantly present in the pancreas of prediabetic BB rats
Q70223138Immunoreactive insulin and C-peptide responses to various insulin secretory stimuli in subjects with type 2 diabetes and in control subjects during continuous glucose monitoring
Q33902884Impact of glucose dosing regimens on modeling of glucose tolerance and β-cell function by intravenous glucose tolerance test in diet-induced obese mice
Q51573060Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance.
Q44564070Impaired cathepsin L gene expression in skeletal muscle is associated with type 2 diabetes
Q43806842Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations
Q43720039Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men.
Q35649213Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies
Q28565526Important role of phosphodiesterase 3B for the stimulatory action of cAMP on pancreatic beta-cell exocytosis and release of insulin
Q44295533Improved beta-cell function after standardized weight reduction in severely obese subjects
Q35928257Improved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolism
Q54153850Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice.
Q70287284Improved insulin release to carbachol after vagotomy in rats-an effect due to cholinergic supersensitivity of the β-cells?
Q33509686Improved insulin sensitivity and islet function after PPARdelta activation in diabetic db/db mice
Q33220335Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year
Q46907739Improved meal-related insulin processing contributes to the enhancement of B-cell function by the DPP-4 inhibitor vildagliptin in patients with type 2 diabetes
Q39799361Improved metabolic risk markers following two 6-month physical activity programs among socioeconomic marginalized women of Native American ancestry in Lima, Peru
Q46979672Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia.
Q69798468Improvement of liver preservation quality with UW solution by chlorpromazine pretreatment of the donor in an experimental model
Q67980093Improvement of the effects of intrasplenic transplantation of hepatocytes after 90% hepatectomy in the rat by cotransplantation with pancreatic islets
Q46917075In vivo and in vitro glucose-induced biphasic insulin secretion in the mouse: pattern and role of cytoplasmic Ca2+ and amplification signals in beta-cells
Q47558789Increased insulin clearance in mice with double deletion of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors
Q50864761Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin).
Q43852281Increased insulin secretion in response to glucose in isolated islets of Langerhans from bile duct-occluded rats
Q44357255Increased insulin sensitivity is associated with reduced insulin and glucagon secretion and increased insulin clearance in man.
Q54685218Increased passage of bovine serum albumin over the respiratory tract after intratracheal instillation during septic shock in rats.
Q51531645Increased β-cell volume in mice fed a high-fat diet: a dynamic study over 12 months
Q46494673Incretin and islet hormonal responses to fat and protein ingestion in healthy men.
Q47426813Incretin and islet hormone responses to meals of increasing size in healthy subjects
Q53365314Incretin effect after oral amino acid ingestion in humans.
Q51032753Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans
Q50915104Incretin hormone receptors are required for normal beta cell development and function in female mice
Q37811413Incretin hormone secretion over the day.
Q83858750Incretin hormones and the up-regulation of insulin secretion in insulin resistance
Q87368933Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial
Q91676517Incretin-based medications (GLP-1 receptor agonists, DPP-4 inhibitors) as a means to avoid hypoglycaemic episodes
Q68862818Influence of bile duct occlusion on plasma insulin responses to glucose in rats
Q70503575Influence of peri-arterial hepatic denervation on the glycemic response to exercise in rats
Q68452003Influence of phosphatidylcholine on intra-abdominal adhesion formation and peritoneal macrophages
Q42446149Influence of the sympatho-adrenal system and somatostatin on the secretion of insulin in the rat
Q48200185Influences of Breakfast on Clock Gene Expression and Postprandial Glycemia in Healthy Individuals and Individuals With Diabetes: A Randomized Clinical Trial.
Q72684099Influences of Gastro-Intestinal Polypeptides and Glucose on Glucagon Secretion Induced by Cholinergic Stimulation
Q72161963Inhibition by rat diazepam-binding inhibitor/acyl-CoA-binding protein of glucose-induced insulin secretion in the rat
Q40103150Inhibition by somatostatin of mouse thyroid activity following stimulation by thyrotrophin, isoprenaline and dibutyryl cyclic-AMP
Q69904267Inhibition of 2-deoxy-glucose-induced glucagon secretion by muscarinic and alpha-adrenoceptor blockade in the mouse
Q43972608Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes
Q81157658Inhibition of dipeptidyl peptidase-4 augments insulin secretion in response to exogenously administered glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, pituitary adenylate cyclase-activating polypeptide, and gastrin-releasing
Q28260260Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes
Q44704981Inhibition of lipase activity and lipolysis in rat islets reduces insulin secretion
Q35871904Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?
Q37611960Inhibitory effect of kisspeptins on insulin secretion from isolated mouse islets
Q41114034Inhibitory effect of somatostatin on insulin secretion during alpha-adrenergic blockade in three different species
Q44129319Insufficient islet compensation to insulin resistance vs. reduced glucose effectiveness in glucose-intolerant mice
Q51280702Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation.
Q68159132Insulin and C-peptide secretory responses to glucagon in man: studies on the dose-response relationships
Q74456442Insulin and glucagon secretion by ganglionic nicotinic activation in adrenalectomized mice
Q42504927Insulin and glucagon secretion in rats: effects of calcitonin gene-related peptide
Q69275582Insulin and glucagon secretion in streptozotocin-diabetic rats: influences of islets transplanted to the renal subcapsular space
Q70164174Insulin and glucagon secretion in swimming mice: effects of adrenalectomy and chemical sympathectomy
Q44745649Insulin and glucagon secretion in swimming mice: effects of autonomic receptor antagonism
Q64228179Insulin and incretin hormone responses to rapid versus slow ingestion of a standardized solid breakfast in healthy subjects
Q37598881Insulin plus incretin: A glucose-lowering strategy for type 2-diabetes
Q51560877Insulin resistant subjects lack islet adaptation to short-term dexamethasone-induced reduction in insulin sensitivity.
Q33224079Insulin secretion after dietary supplementation with conjugated linoleic acids and n-3 polyunsaturated fatty acids in normal and insulin-resistant mice
Q44887107Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance
Q33275901Insulin secretion and insulin sensitivity in relation to fasting glucose in healthy subjects
Q42491276Insulin secretion and islet lysosomal enzyme activities in the mouse. Effects of suramin.
Q42045839Insulin secretion and lysosomal enzyme activities in isolated mouse islets. Effects of glucose, diazoxide and isobutylmethylxanthine.
Q74153623Insulin secretion by gastrin-releasing peptide in mice: ganglionic versus direct islet effect
Q69315563Insulin secretion in neonatally streptozotocin-injected mice
Q43564357Insulin secretion in rats: effects of neuropeptide Y and noradrenaline
Q70122003Insulin secretion in streptozotocin-diabetic rats transplanted with immunoisolated islets
Q72513743Insulin secretion induced by glucose and by stimulation of beta 2 -adrenoceptors in the rat. Different sensitivity to somatostatin
Q72491194Insulin secretory response to different secretagogues in hyper- and hypothyroid mice
Q44616504Insulin sensitivity, insulin secretion, and glucose tolerance versus intima-media thickness in nondiabetic postmenopausal women
Q52544667Insulin-like growth factor II plays a central role in atherosclerosis in a mouse model.
Q72545349Interaction of gastric inhibitory polypeptide (GIP) and cholecystokinin (CCK-8) with basal and stimulated insulin secretion in mice
Q44913553Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction
Q43851625Interleukin-6-deficient mice develop mature-onset obesity
Q43591084Intermittent hepatic arterial or portal occlusion reduces liver tumor growth
Q42481230Intermittent hepatic dearterialization induces glucose intolerance: an experimental study in the rat.
Q73476404Intraperitoneal PACAP administration decreases blood glucose in GK rats, and in normal and high fat diet mice
Q72762392Involvement of capsaicin-sensitive nerves in regulation of insulin secretion and glucose tolerance in conscious mice
Q71583350Involvement of nitric oxide in neuroglycopenia-induced insulin and glucagon secretion in the mouse
Q71712887Involvement of phospholipase A2 and arachidonic acid in cholecystokinin-8-induced insulin secretion in rat islets
Q39030736Ischaemic and metabolic treatment of hepatic tumours
Q37443837Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
Q90113735Islet adaptation in GIP receptor knockout mice
Q36005145Islet adaptation to insulin resistance: mechanisms and implications for intervention
Q67875638Islet allotransplantation to streptozotocin-diabetic rats. Effects of multistrain donation and ultraviolet light irradiation
Q33912902Islet amyloid and type 2 diabetes mellitus
Q71469934Islet amyloid polypeptide (amylin) and insulin are differentially expressed in chronic diabetes induced by streptozotocin in rats
Q73634180Islet amyloid polypeptide (amylin)-deficient mice develop a more severe form of alloxan-induced diabetes
Q51578239Islet amyloid polypeptide and insulin gene expression are regulated in parallel by glucose in vivo in rats.
Q51556021Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance.
Q51582214Islet dysfunction in obese women with impaired glucose tolerance.
Q44142711Islet function phenotype in gastrin-releasing peptide receptor gene-deficient mice
Q41946992Islet hormone secretion and islet lysosomal enzyme activities in the mouse: effects of chloroquine.
Q73838344Islet phospholipase A(2) activation is potentiated in insulin resistant mice
Q69261583Islet transplantation to the renal subcapsular space in streptozotocin-diabetic rats. Long-term effects on insulin and glucagon secretion
Q69243778Kinetics of radioiodine released from prelabelled thyroid gland in vivo: influence of propylthiouracil
Q39181694Large differences in serum leptin levels between nonwesternized and westernized populations: the Kitava study
Q43844459Leptin concentrations are increased in subjects treated with clozapine or conventional antipsychotics
Q48290307Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort
Q54070456Leptin is associated with increased risk of myocardial infarction.
Q80043586Leptin is closely related to body fat in prepubertal children aged 8-11 years
Q57938596Leptin is reduced in lean subjects with type 2 diabetes in bangladesh
Q50912358Leptin--a regulator of islet function?: its plasma levels correlate with glucagon and insulin secretion in healthy women
Q36220895Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial)
Q68015734Liver cirrhosis in rats: regeneration and assessment of the role of phenobarbital
Q70733685Liver regeneration following 68% partial orthotopic liver transplantation in the rat
Q43651804Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism.
Q44419324Local Growth Factors Are Beneficial for the Autonomic Reinnervation of Transplanted Islets in Rats
Q44971975Localization of calcitonin gene-related peptide and islet amyloid polypeptide in the rat and mouse pancreas
Q70528849Long-term diabetogenic effect of streptozotocin in rats
Q71923179Long-term effects of alloxan in mice
Q43973972Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice
Q74141538Long-term leptin treatment of ob/ob mice improves glucose-induced insulin secretion
Q44814498Loss-of-function mutation of the galanin gene is associated with perturbed islet function in mice
Q47380156Low CSF leptin in female suicide attempters with major depression
Q42476819Low adipocyte IRS-1 protein expression is associated with an increased arterial stiffness in non-diabetic males
Q39181702Low serum insulin in traditional Pacific Islanders--the Kitava Study
Q54116263Marked hyperleptinemia after high-fat diet associated with severe glucose intolerance in mice.
Q61480334Mature-Onset Obesity in Interleukin-1 Receptor I Knockout Mice
Q37867193Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans
Q72371088Mechanisms underlying the insulinostatic effect of peptide YY in mouse pancreatic islets
Q41564006Methods and models for metabolic assessment in mice
Q45056312Milrinone efficiently potentiates insulin secretion induced by orally but not intravenously administered glucose in C57BL6J mice
Q68270083Mitomycin C and lipiodol do not improve the effect of intermittent hepatic artery occlusion on liver tumour growth. An experimental study in the rat
Q40557047Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes
Q70233490Modulation of basal insulin secretion in the obese, hyperglycemic mouse
Q74631706Modulatory role of adrenergic nerves on dexamethasone-induced islet cell NPY expression in the rat: evidence from chemical sympathectomy
Q69552062Monoamines in pancreatic islets of guinea pig, hamster, rat, and mouse determined by high performance liquid chromatography
Q71664555N-terminally elongated fragments of galanin(1-16) inhibit insulin secretion from isolated mouse islets
Q28316273Neonatal capsaicin-treatment in mice: effects on pancreatic peptidergic nerves and 2-deoxy-D-glucose-induced insulin and glucagon secretion
Q42212928Neuropeptide Y and calcitonin gene-related peptide: effects on glucagon and insulin secretion in the mouse
Q48068593Neuropeptide Y is expressed in subpopulations of insulin- and non-insulin-producing islet cells in the rat after dexamethasone treatment: a combined immunocytochemical and in situ hybridisation study
Q42522242Neuropeptide Y: intrapancreatic neuronal localization and effects on insulin secretion in the mouse
Q39462385Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion
Q72701024Neuropeptides in the Thyroid Gland: Distribution of Substance P and Gastrin/Cholecystokinin and Their Effects on the Secretion of Iodothyronine and Calcitonin*
Q36525819Neuropeptides in the regulation of islet hormone secretion--localization, effects and mode of action
Q46400145New strategy in type 2 diabetes tested in clinical trials. Glucagon-like peptide 1 (GLP-1) affects basic caused of the disease
Q51572132No correlation between insulin and islet amyloid polypeptide after stimulation with glucagon-like peptide-1 in type 2 diabetes.
Q72348992Non-parallelism of islet amyloid polypeptide (amylin) and insulin gene expression in rats islets following dexamethasone treatment
Q69928277Nonadrenergic sympathetic neural influences on basal pancreatic hormone secretion
Q36812821Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin
Q69106993On the nature of the galanin action on the endocrine pancreas: studies with six galanin fragments in the perfused dog pancreas
Q53737560Once weekly glucagon-like peptide-1 receptor agonist albiglutide vs. prandial insulin added to basal insulin in patients with type 2 diabetes mellitus: Results over 52 weeks.
Q42831349Overexpression of Foxf2 in adipose tissue is associated with lower levels of IRS1 and decreased glucose uptake in vivo
Q32076408Overweight is associated with lower serum leptin in Peruvian Indian than in Caucasian women: A dissociation contributing to low blood pressure?
Q58448777PACAP contributes to insulin secretion after gastric glucose gavage in mice
Q74612429PACAP is an islet neuropeptide which contributes to glucose-stimulated insulin secretion
Q44397753PACAP is expressed in secretory granules of insulin and glucagon cells in human and rodent pancreas. Evidence for generation of cAMP compartments uncoupled from hormone release in diabetic islets
Q48014626PACAP stimulates insulin secretion but inhibits insulin sensitivity in mice
Q40825758PACAP27 sensitizes glucose induced insulin secretion in INS-1 cells
Q44618182Pancreastatin inhibits insulin secretion and exocrine pancreatic secretion in the pig.
Q68139524Pancreastatin inhibits insulin secretion and stimulates glucagon secretion in mice
Q43466841Pancreastatin inhibits insulin secretion from isolated rat islets: studies on its mechanism of action
Q71697302Pancreastatin modulates glucose-stimulated insulin secretion from the perfused rat pancreas
Q43579253Pancreatic Release of Pancreastatin in the Pig
Q44527061Pancreatic beta-cell lipotoxicity induced by overexpression of hormone-sensitive lipase
Q54566890Pancreatic exocrine secretion during the first days after weaning in pigs.
Q42465732Pancreatic function in the essential fatty acid deficient rat
Q69104272Pancreatic nerve stimulation releases neuropeptide Y- but not galanin- or calcitonin gene-related peptide-like immunoreactivity from the pig pancreas
Q72746749Pancreatic peptide YY in alloxan diabetic mice
Q44255639Pancreatic procolipase activation peptide-enterostatin-inhibits pancreatic enzyme secretion in the pig.
Q67522369Pancreatic tumors in multiple endocrine neoplasia type 1: clinical presentation and surgical treatment
Q42516766Peptide YY does not inhibit glucose-stimulated insulin secretion in humans
Q42496974Peptide YY: intrapancreatic localization and effects on insulin and glucagon secretion in the mouse.
Q68078458Peptide receptor antagonists in the study of insulin and glucagon secretion in mice
Q91596747Persistent whole day meal effects of three dipeptidyl peptidase-4 inhibitors on glycaemia and hormonal responses in metformin-treated type 2 diabetes
Q68207435Phosphatidylcholine prevents postoperative peritoneal adhesions: an experimental study in the rat
Q33918661Phospholipase A2 and its potential regulation of islet function
Q54250223Phospholipase-resistant phosphatidylcholine reduces intra-abdominal adhesions induced by bacterial peritonitis.
Q35760279Physiology of incretins in health and disease
Q41144147Pituitary adenylate cyclase-activating polypeptide (PACAP) and insulin secretion: effects and mechanisms
Q42456246Pituitary adenylate cyclase-activating polypeptide (PACAP): occurrence in rodent pancreas and effects on insulin and glucagon secretion in the mouse
Q73668365Pituitary adenylate cyclase-activating polypeptide stimulates insulin and glucagon secretion in humans
Q46831311Plasma calcitonin gene-related peptide is increased prior to obesity, and sensory nerve desensitization by capsaicin improves oral glucose tolerance in obese Zucker rats
Q54092903Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women.
Q51578920Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women.
Q51386462Plasma lipid fatty acid composition, desaturase activities and insulin sensitivity in Amerindian women
Q67535249Plasma neuropeptide Y (NPY) and galanin before and during exercise in type 1 diabetic patients with autonomic dysfunction
Q51320196Pleiotropic mechanisms for the glucose-lowering action of DPP-4 inhibitors.
Q43708974Positive correlation between tumor necrosis factor (TNF)-α and cardiorespiratory fitness after six-months of regular aerobic exercise in Peruvian Amerindian women
Q44397771Postnatally disturbed pancreatic islet cell distribution in human islet amyloid polypeptide transgenic mice
Q37239290Postprandial Glucagon Reductions Correlate to Reductions in Postprandial Glucose and Glycated Hemoglobin with Lixisenatide Treatment in Type 2 Diabetes Mellitus: A Post Hoc Analysis
Q40931940Potential therapeutic levels of glucagon-like peptide I achieved in humans by a buccal tablet
Q47718718Potentiated beta-cell response to non-glucose stimuli in insulin-resistant C57BL/6J mice
Q68899159Potentiation of glucose-induced insulin secretion in the perfused rat pancreas by porcine GIP (gastric inhibitory polypeptide), bovine GIP, and bovine GIP(1-39)
Q51552671Prediction of diabetes using ADA or WHO criteria in post-menopausal women: a 10-year follow-up study.
Q67698313Presence of galanin in human pancreatic nerves and inhibition of insulin secretion from isolated human islets
Q73399802Presynaptic sympathetic mechanism in the insulinostatic effect of epinephrine in mouse pancreatic islets
Q47440507Prevention of adhesions by high molecular weight dextran in rats. Re-evaluation in nine experiments
Q41094685Prevention of hyperglycemia improves the long-term result of islet transplantation in streptozotocin-diabetic rats.
Q40976281Protein kinase A inhibition and PACAP-induced insulin secretion in HIT-T15 cells
Q43869368Quantification of insulin secretion in relation to insulin sensitivity in nondiabetic postmenopausal women
Q72140391Quinacrine accumulates in certain peptide hormone-producing cells
Q42527331Quinacrine accumulation in pancreatic islet cells of rat and mouse: relationship to functional activity and effects on basal and stimulated insulin secretion
Q46124613Reappraisal of the intravenous glucose tolerance index for a simple assessment of insulin sensitivity in mice
Q73374281Reclaim the clinical research--proposal to an action plan
Q46676090Reconstructing the pancreas: restoration of normoglycemia, exocrine function, and islet innervation by islet transplantation to the pancreas
Q73127261Reduced GLP-1 and insulin responses and glucose intolerance after gastric glucose in GRP receptor-deleted mice
Q51574097Reduced gastric inhibitory polypeptide but normal glucagon-like peptide 1 response to oral glucose in postmenopausal women with impaired glucose tolerance.
Q46678800Reduced insulin clearance contributes to the increased insulin levels after administration of glucagon-like peptide 1 in mice
Q38331466Reduced pancreatic content of the inhibitory neurotransmitter galanin in genetically obese, hyperinsulinemic mice
Q90239003Reduction in Glycated Hemoglobin and Daily Insulin Dose Alongside Circadian Clock Upregulation in Patients With Type 2 Diabetes Consuming a Three-Meal Diet: A Randomized Clinical Trial
Q41693076Regulation of circulating leptin in humans
Q51562839Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance.
Q40186815Release of cyclic AMP from thyroid cells in vitro
Q69645647Repeated hepatic ischemia as a treatment for carcinoid liver metastases
Q30832022Role of VIP and PACAP in islet function
Q70749975Role of extracellular Na+ on CCK-8-induced insulin secretion
Q34997064Role of islet amyloid in type 2 diabetes mellitus: consequence or cause?
Q37348473Role of pituitary adenylate cyclase-activating polypeptide in the pancreatic endocrine system
Q69740180Secretin potentiates cholinergically induced glucagon secretion in the mouse
Q33518270Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men.
Q69055115Selective alpha 2-adrenoceptor activation by clonidine: effects on 45Ca2+ efflux and insulin secretion from isolated rat islets
Q88688834Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials
Q45284220Sensory nerve desensitization by resiniferatoxin improves glucose tolerance and increases insulin secretion in Zucker Diabetic Fatty rats and is associated with reduced plasma activity of dipeptidyl peptidase IV.
Q46481403Sensory nerve inactivation by resiniferatoxin improves insulin sensitivity in male obese Zucker rats
Q33196495Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice
Q57675752Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease
Q43907217Serum cholesteryl fatty acid composition and plasma glucose concentrations in Amerindian women
Q46246161Serum uric acid in traditional Pacific Islanders and in Swedes
Q46333714Sex-related differences in the associations between hyperleptinemia, insulin resistance and dysfibrinolysis
Q39535313Shifting the paradigm of islet inflammation--good guy or bad guy?
Q51578383Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women.
Q41188277Signaling mechanisms underlying the insulinotropic effect of pituitary adenylate cyclase-activating polypeptide in HIT-T15 cells
Q67285290Single injection of terbutaline in term labor: placental transfer and effects on maternal and fetal carbohydrate metabolism
Q42440190Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function
Q73548806Smoking habits and circulating leptin in postmenopausal non-obese women
Q39309820Somatostatin inhibits thyroid hormone secretion induced by exogenous TSH in man
Q70941516Stimulation of endocrine, but not exocrine, pancreatic secretion during 2-deoxy-D-glucose-induced neuroglycopenia in the conscious pig
Q34239151Stimulation of peripheral T3 formation by oral but not by intravenous glucose administration in fasted subjects
Q71902529Stimulation of somatostatin secretion by 3-O-methylglucose in the perfused dog pancreas
Q67713791Studies on the mechanism by which galanin inhibits insulin secretion in islets
Q71797626Studies on the mechanisms by which gastrin releasing peptide potentiates glucose-induced insulin secretion from mouse islets
Q33722778Study on administration of 1,5-anhydro-D-fructose in C57BL/6J mice challenged with high-fat diet
Q36711962Subtotal pancreatectomy for cancer: closure of the pancreatic remnant with staplers
Q68665671Subtotal pancreatectomy with stapling the pancreatic remnant
Q38315285Suppression of apolipoprotein M expression and secretion in alloxan-diabetic mouse: Partial reversal by insulin
Q43487999Surgical treatment of pancreatic cancer. The Swedish experience
Q51321546Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis.
Q61774856Surrogate measures of insulin sensitivity vs the hyperinsulinaemic–euglycaemic clamp: a meta-analysis. Are there not some surrogate indexes lost in this story? Reply to Bastard JP, Rabasa-Lhoret R, Laville M and Disse E [letter]
Q45173103Survivors of childhood acute lymphoblastic leukaemia, with radiation-induced GH deficiency, exhibit hyperleptinaemia and impaired insulin sensitivity, unaffected by 12 months of GH treatment
Q42498750Switching from high-fat to low-fat diet normalizes glucose metabolism and improves glucose-stimulated insulin secretion and insulin sensitivity but not body weight in C57BL/6J mice
Q68161208Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 1). Effects on basal release of insulin and glucagon
Q69900988Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 2). Effects on basal release of somatostatin and pancreatic polypeptide
Q51328388Synergism by individual macronutrients explains the marked early GLP-1 and islet hormone responses to mixed meal challenge in mice.
Q72409787Temperature-dependent phospholipid degradation in the rat liver during preservation for transplantation. A comparison between different preservation solutions
Q51773944Temporal and dietary fat content-dependent islet adaptation to high-fat feeding-induced glucose intolerance in mice.
Q89498811The Incretin Effect in Female Mice With Double Deletion of GLP-1 and GIP Receptors
Q68229409The Intestinal Peptide PEC-60 Inhibits Insulin Secretion in the Mouse and the Rat
Q88312476The Vildagliptin Experience - 25 Years Since the Initiation of the Novartis Glucagon-like Peptide-1 Based Therapy Programme and 10 Years Since the First Vildagliptin Registration
Q28257815The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice
Q44111025The association between leptin and proinsulin is lost with central obesity
Q46677441The augmenting effect on insulin secretion by oral versus intravenous glucose is exaggerated by high-fat diet in mice
Q33697322The canine sympathetic neuropeptide galanin: a neurotransmitter in pancreas, a neuromodulator in liver
Q43596007The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia
Q73492486The cyclic AMP-protein kinase A pathway restrains islet phospholipase A(2) activation
Q83540652The dynamic incretin adaptation and type 2 diabetes
Q71741934The effect of cholecystokinin on proinsulin gene expression in isolated mouse pancreatic islets
Q67830219The effect of pancreatic islets on transplanted hepatocytes in the treatment of acute liver failure in rats
Q73476399The effects of PACAP on insulin secretion and glucose disposal are altered by adrenalectomy in mice
Q69924694The effects of epinephrine on islet hormone secretion in the dog
Q67923348The function of a colloid in liver cold-storage preservation
Q57113924The functional effects of suppression of hypothermia-induced cell swelling in liver preservation by cold storage
Q31131756The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes
Q84886846The hyperstimulated β-cell: prelude to diabetes?
Q79614917The impact of large tidal volume ventilation on the absorption of inhaled insulin in rabbits
Q73008426The influence of potato fibre on exocrine pancreatic secretions and on plasma levels of insulin, secretin and cholecystokinin in growing pigs
Q33236116The insulin response to gastric glucose is reduced in PAC1 and GRP receptor gene deleted mice
Q37082836The islet enhancer vildagliptin: mechanisms of improved glucose metabolism
Q40501404The major glucagon-like peptide-1 metabolite, GLP-1-(9-36)-amide, does not affect glucose or insulin levels in mice
Q68860966The mechanism of vagal nerve stimulation of glucagon and insulin secretion in the dog
Q85304394The neuro-incretin concept
Q34346667The neuropeptide pituitary adenylate cyclase-activating polypeptide and islet function
Q67537121The novel high-affinity antagonist, galantide, blocks the galanin-mediated inhibition of glucose-induced insulin secretion
Q42078964The presence and actions of NPY in the canine endocrine pancreas
Q73143729The relationship between leptin and the insulin resistance syndrome is disturbed in type 2 diabetic subjects with parasympathetic neuropathy
Q42467771Three-day enteral exposure to a red kidney bean lectin preparation enhances the pancreatic response to CCK stimulation in suckling pigs
Q38690890Three-year data from 5 HARMONY phase 3 clinical trials of albiglutide in type 2 diabetes mellitus: Long-term efficacy with or without rescue therapy
Q71603608Tissue-specific reduction of galanin content in the pancreas in alloxan diabetes in the mouse
Q80581370Traditional versus agricultural lifestyle among Shuar women of the Ecuadorian Amazon: effects on leptin levels
Q50855262Transgenic overexpression of human islet amyloid polypeptide inhibits insulin secretion and glucose elimination after gastric glucose gavage in mice
Q41917750Treatment of pancreatic fistula with the somatostatin analogue SMS 201-995.
Q33209301Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes
Q46795693Two breakthroughs in the treatment of type 2 diabetes. Both the receptor agonist and enzyme inhibitors now available in the clinic
Q37857686Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin
Q59054209VIP occurs in intrathyroidal nerves and stimulates thyroid hormone secretion
Q70500881VIP-stimulated thyroid hormone secretion: effects of other neuropeptides and alpha- or beta-adrenoceptor blockade
Q45129958VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes
Q51741479Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3).
Q42962663Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study
Q46143605Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes
Q34362258Vildagliptin reduces glucagon during hyperglycemia and sustains glucagon counterregulation during hypoglycemia in type 1 diabetes
Q33237060Vildagliptin: an inhibitor of dipeptidyl peptidase-4 with antidiabetic properties
Q79152966[Clinical research must be based on teaming physician and researcher]
Q53980330[Diabetes and the driving license. Studies of insulin and C-peptide levels]
Q67259014[Glycosylated hemoglobin and control of diabetes]
Q69631391[Ischemic treatment of cancer--a break-through?]
Q71481599[The "diabetes" nurse can manage the classification of metabolic control better than the patient]
Q84636575[Warning against uncritical use of overweight surgery in type 2 diabetes]
Q84689763β-Cell research - A decade of rapid growth

Q5544511Per-Olov AhrénchildP40

The articles in Wikimedia projects and languages

      Bo Ahrénwikipedia

Search more.